Merck's Diarrhea Drug Could be First in 30 Years
A Merck-licensed drug to fight a bacteria blamed for increasing rates of deadly diarrhea in hospitals and nursing homes was found to cut repeat infections by 72%. The drug reduces the risk of re-infection by the bug and its more virulent new strain more than in patients taking only antibiotics.
